SHENZHEN HAISG BIOTECH Co.,LTD – Trademark Portfolio
Entity Type: 99
SHENZHEN HAISG BIOTECH Co.,LTD has 3 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 100% registration rate. The portfolio includes marks such as HXCARE. Filings span 3 Nice Classification classes, with the highest activity in Class 10 (Medical Apparatus) and Class 5 (Pharmaceuticals). This trademark owner is based in Shenzhen, Guangdong.
Rm.306, Bldg. A11, No.140, Jinye Avenue
Kuiyong Street, Dapeng New District
Shenzhen, Guangdong 518119 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHENZHEN HAISG BIOTECH Co.,LTD's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does SHENZHEN HAISG BIOTECH Co.,LTD have?
SHENZHEN HAISG BIOTECH Co.,LTD has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does SHENZHEN HAISG BIOTECH Co.,LTD file in?
SHENZHEN HAISG BIOTECH Co.,LTD files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are SHENZHEN HAISG BIOTECH Co.,LTD's most well-known trademarks?
SHENZHEN HAISG BIOTECH Co.,LTD's registered trademark portfolio includes well-known marks such as HXCARE. These are among 3 currently registered trademarks in the portfolio.
What is SHENZHEN HAISG BIOTECH Co.,LTD's trademark registration success rate?
SHENZHEN HAISG BIOTECH Co.,LTD has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.